Psychedelics Scientists coin the term ‘PiPi drugs’: a new frontier in psychedelic medicine Non-psychoactive therapeutics derived from psychedelic compounds have promising anti-inflammatory properties Rowan DunneSeptember 5, 2025
Psychedelics American priest ousted by church for psilocybin advocacy He thinks magic mushrooms are spiritually elevating but his former religious overlords are not so enthused Rowan DunneSeptember 2, 2025
Psychedelics Pharma giant AbbVie to spend over US$1B on Gilgamesh’s lead psychedelic One of the biggest deals of all time in the industry Rowan DunneAugust 27, 2025
Psychedelics Sarpa salpa: the psychedelic fish you’ve probably never heard of If you eat its brain or liver you will trip serious balls for up to 36 hours Rowan DunneAugust 21, 2025
Psychedelics Mexican ibogaine clinic sees increasing number of veteran guests New funding initiatives and emerging research are making these centres pull the spotlight Rowan DunneAugust 12, 2025
Psychedelics Germany becomes 1st EU nation to prescribe psilocybin for depression The country's Central Institute of Mental Health says it will be used in 'justified exceptional cases' only Rowan DunneAugust 6, 2025
Psychedelics African psilocybin cultivator ‘Psyence’ gets C$600K investment The final C$124,000-dollar tranche was obtained on Jul. 4 Rowan DunneJuly 10, 2025
Psychedelics Osama bin Laden’s killer advocates for ibogaine therapy In an interview with Tucker Carlson, Rob O'Neill said psychedelics were the key for alleviating PTSD symptoms Rowan DunneJuly 8, 2025
Psychedelics FDA gives another one of Filament Health’s psilocybin trials green light The news follows the agency approving a Phase 2 study on PEX010 for different indications in April Rowan DunneJuly 7, 2025
Psychedelics Psychedelic drug developer Cybin secures major financing deal The convertible debentures will raise up to half a billion Rowan DunneJuly 2, 2025